Perspectives on Biologically Active Camptothecin Derivatives

Camptothecins (CPTs) are cytotoxic natural alkaloids that specifically target DNA topoisomerase I. Research on CPTs has undergone a significant evolution from the initial discovery of CPT in the late 1960s through the study of synthetic small‐molecule derivatives to investigation of macromolecular constructs and formulations. Over the past years, intensive medicinal chemistry efforts have generated numerous CPT derivatives. Three derivatives, topotecan, irinotecan, and belotecan, are currently prescribed as anticancer drugs, and several related compounds are now in clinical trials. Interest in other biological effects, besides anticancer activity, of CPTs is also growing exponentially, as indicated by the large number of publications on the subject during the last decades. Therefore, the main focus of the present review is to provide an ample but condensed overview on various biological activities of CPT derivatives, in addition to continued up‐to‐date coverage of anticancer effects.

[1]  J. Chern,et al.  Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy. , 2008, Journal of medicinal chemistry.

[2]  B. Das,et al.  Two efficient methods for the conversion of camptothecin to mappicine ketone, an antiviral lead compound☆ , 1998 .

[3]  A. Grollman,et al.  Studies on camptothecin. I. Effects of nucleic acid and protein synthesis. , 1971, Molecular pharmacology.

[4]  Ying-Qian Liu,et al.  Synthesis of novel derivatives of camptothecin as potential insecticides , 2010 .

[5]  F. Zunino,et al.  Synthesis and cytotoxic activity of substituted 7-aryliminomethyl derivatives of camptothecin. , 2004, European journal of medicinal chemistry.

[6]  C. Bailly,et al.  Topoisomerase I-mediated antiproliferative activity of enantiomerically pure fluorinated homocamptothecins. , 2000, Journal of medicinal chemistry.

[7]  A. Bodley,et al.  Antitrypanosomal activity of camptothecin analogs. Structure-activity correlations. , 1995, Biochemical pharmacology.

[8]  Shengzheng Wang,et al.  Synthesis and biological evaluation of novel 7-acyl homocamptothecins as Topoisomerase I inhibitors. , 2011, European journal of medicinal chemistry.

[9]  Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues. , 1998, Journal of medicinal chemistry.

[10]  D. Blair,et al.  The topoisomerase I inhibitor, camptothecin, inhibits equine infectious anemia virus replication in chronically infected CF2Th cells , 1991, Journal of virology.

[11]  R. DeJager,et al.  A Phase II Study of Intravenous Exatecan Mesylate (DX-8951f) Administered Daily for Five Days Every Three Weeks to Patients with Metastatic Adenocarcinoma of the Colon or Rectum , 2004, Investigational New Drugs.

[12]  L. Rudnicka,et al.  The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis , 2001, Arthritis research.

[13]  L. Grochow,et al.  Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  R J Reitemeier,et al.  Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer. , 1972, Cancer chemotherapy reports.

[15]  Xiran Lin,et al.  Effects of isocamptothecin, a novel camptothecin analogue, on proliferation, apoptosis and telomerase activity in HaCaT cells , 2008, Experimental dermatology.

[16]  A. Guarino,et al.  Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880). , 1970, Cancer chemotherapy reports.

[17]  E. Farber,et al.  Camptothecin induces differentiation, tissue transglutaminase and apoptosis in cultured keratinocytes , 1998, Experimental dermatology.

[18]  H. Fiebig,et al.  Design and optimization of 20-O-linked camptothecin glycoconjugates as anticancer agents. , 2001, Journal of medicinal chemistry.

[19]  J. Singer,et al.  Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Ying-Qian Liu and Synthesis and Insecticidal Activities of Novel Spin-Labeled Derivatives of Camptothecin. , 2012 .

[21]  John H Cardellina,et al.  Identification of a new natural camptothecin analogue in targeted screening for HIF-1alpha inhibitors. , 2006, Planta medica.

[22]  P. Sinko,et al.  ASeries of r-AminoAcid Ester Prodrugs of Camptothecin : In VitroHydrolysis and A 549 Human Lung Carcinoma Cell Cytotoxicity , 2010 .

[23]  L. Keus,et al.  Feasibility, phase I, and pharmacological study of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced malignancies in the lungs. , 2006, Annals of the New York Academy of Sciences.

[24]  F. Zunino,et al.  Gimatecan, a novel camptothecin with a promising preclinical profile , 2004, Anti-cancer drugs.

[25]  Jai-Sing Yang,et al.  Design, Synthesis, Mechanisms of Action, and Toxicity of Novel 20(S)-Sulfonylamidine Derivatives of Camptothecin as Potent Antitumor Agents , 2014, Journal of medicinal chemistry.

[26]  Wei Guo,et al.  Synthesis and evaluation of 9-benzylideneamino derivatives of homocamptothecin as potent inhibitors of DNA topoisomerase I. , 2010, European journal of medicinal chemistry.

[27]  H. Li,et al.  Effect of topical use of camptothecine-dimethyl sulfoxide solution in psoriasis. , 1975, Chinese medical journal.

[28]  G. Bubley,et al.  Microwave expedited synthesis of 5-aminocamptothecin analogs: Inhibitors of hypoxia inducible factor HIF-1alpha. , 2006, Bioorganic & medicinal chemistry letters.

[29]  A. Grollman,et al.  Antiviral Action of Camptothecin , 1972, Antimicrobial Agents and Chemotherapy.

[30]  Y. Pommier,et al.  Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1 , 2004, Cancer Research.

[31]  K. Yamauchi,et al.  The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer. , 2007, Anticancer research.

[32]  Y. Zu,et al.  Synthesis and antitumor activity of novel 20s-camptothecin analogues. , 2009, Bioorganic & medicinal chemistry letters.

[33]  C. Crumpacker,et al.  Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  F. Zunino,et al.  Preclinical efficacy of ST1976, a novel camptothecin analog of the 7-oxyiminomethyl series. , 2007, Biochemical pharmacology.

[35]  A. Venkateswarlu,et al.  Novel C-ring analogues of 20(S)-camptothecin-part-2: synthesis and in vitro cytotoxicity of 5-C-substituted 20(S)-camptothecin analogues. , 1999, Bioorganic & medicinal chemistry letters.

[36]  F. Meng,et al.  14-Aminocamptothecins: their synthesis, preclinical activity, and potential use for cancer treatment. , 2011, Journal of medicinal chemistry.

[37]  S. Moro,et al.  Semisynthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecins. , 2009, Journal of medicinal chemistry.

[38]  E K Rowinsky,et al.  The current status of camptothecin analogues as antitumor agents. , 1993, Journal of the National Cancer Institute.

[39]  Li-xi Yang,et al.  Synthesis and pharmacology of new camptothecin drugs. , 2005, Mini-Reviews in Medical Chemistry.

[40]  C. Bailly,et al.  The homocamptothecin BN 80915 is a highly potent orally active topoisomerase I poison , 2001, Anti-cancer drugs.

[41]  Y. Pommier Topoisomerase I inhibitors: camptothecins and beyond , 2006, Nature Reviews Cancer.

[42]  M. Cumming,et al.  Antiangiogenic potential of camptothecin and topotecan , 1999, Cancer Chemotherapy and Pharmacology.

[43]  Wen-Qun Li,et al.  Antifeedant Activity of Camptothecin and its Semisynthetic Derivatives Against Spodoptera litura (Fabricius) (Lepidoptera: Noctuidae) Larvae , 2012 .

[44]  Q. You,et al.  Novel hexacyclic camptothecin derivatives. Part 1: synthesis and cytotoxicity of camptothecins with an A-ring fused 1,3-oxazine ring. , 2008, Bioorganic & medicinal chemistry letters.

[45]  A. Venkateswarlu,et al.  Novel C-ring analogues of 20(S)-camptothecin. Part 3: synthesis and their in vitro cytotoxicity of A-, B- and C-ring analogues. , 2000, Bioorganic & medicinal chemistry letters.

[46]  L. Lou,et al.  7-Cycloalkylcamptothecin derivatives: Preparation and biological evaluation. , 2009, Bioorganic & medicinal chemistry letters.

[47]  S. Sawada,et al.  Synthesis and antitumor activity of 20(S)-camptothecin derivatives: A-ring modified and 7,10-disubstituted camptothecins. , 1991, Chemical & pharmaceutical bulletin.

[48]  R. Kiss,et al.  Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties. , 1999, Cancer research.

[49]  Shannon J. Thomas,et al.  On the role of E-ring oxygen atoms in the binding of camptothecin to the topoisomerase I-DNA covalent binary complex. , 2005, Bioorganic & medicinal chemistry.

[50]  Shengzheng Wang,et al.  Synthesis and preliminary bioevaluation of novel E-ring modified acetal analog of camptothecin as cytotoxic agents. , 2012, European journal of medicinal chemistry.

[51]  H. Tian,et al.  Topical Camptothecine in Treatment of Psoriasis , 1988 .

[52]  S. Hecht,et al.  14-azacamptothecin: a potent water-soluble topoisomerase I poison. , 2005, Journal of the American Chemical Society.

[53]  Ying-Qian Liu,et al.  Anti-HSV activity of camptothecin analogues , 2010, Natural product research.

[54]  Xiaoyan Chen,et al.  Development and validation of a sensitive LC-MS/MS method for simultaneous quantification of sinotecan and its active metabolite in human blood. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[55]  A. Demilo,et al.  Camptothecin, a potent chemosterilant against the house fly. , 1974, Journal of economic entomology.

[56]  Zhang Liqin,et al.  Insecticidal effect of camptothecin against Nilaparvata Lugens, Brevicoryne Brassicae and Chilosuppressalis Walker. , 2009 .

[57]  Shiping Zhu,et al.  A new strategy to improve the metabolic stability of lactone: discovery of (20S,21S)-21-fluorocamptothecins as novel, hydrolytically stable topoisomerase I inhibitors. , 2013, Journal of medicinal chemistry.

[58]  A. Lorence,et al.  Camptothecin, over four decades of surprising findings. , 2004, Phytochemistry.

[59]  I. Naguibneva,et al.  Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cells. , 2001, Cancer research.

[60]  Min Huang,et al.  Synthesis and antitumor activity of 7-ethyl-9-alkyl derivatives of camptothecin. , 2005, Bioorganic & Medicinal Chemistry Letters.

[61]  M. Geng,et al.  Synthesis and antitumor activity of 10-arylcamptothecin derivatives. , 2011, Bioorganic & medicinal chemistry letters.

[62]  S. Segal,et al.  Inhibition of retrovirus-induced disease in mice by camptothecin , 1993, Journal of virology.

[63]  Zhang Li-qin Nematocidal activity against pine wood nematode (Bursaphelenchus xylophilus) of 7-C-substituted 20-(S)-camptothecins , 2011 .

[64]  S. Ahn,et al.  Practical synthesis of (S)‐7‐(2‐isopropylamino)ethylcamptothecin hydrochloride, potent topoisomerase I inhibitor , 2000 .

[65]  Wang Wenxiang,et al.  Induced apoptosis of camptothecin in Spodoptera frugiperda Sf9 cells. , 2011 .

[66]  P. Pantazis Camptothecin: A Promising Antiretroviral Drug. , 1996, Journal of biomedical science.

[67]  J. Heitman,et al.  Comparison of In Vitro Activities of Camptothecin and Nitidine Derivatives against Fungal and Cancer Cells , 1999, Antimicrobial Agents and Chemotherapy.

[68]  P. Pantazis,et al.  9-nitrocamptothecin selectively inhibits human immunodeficiency virus type 1 replication in freshly infected parental but not 9-nitrocamptothecin-resistant U937 monocytoid cells. , 1999, AIDS research and human retroviruses.

[69]  E. De Clercq Antiviral drugs: current state of the art. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[70]  J. O’Leary,et al.  Camptothecins: a review of their development and schedules of administration. , 1998, European journal of cancer.

[71]  Wei Guo,et al.  Synthesis and Biological Evaluation of 7‐Alkenyl Homocamptothecins as Potent Topoisomerase I Inhibitors , 2012, Chemistry & biodiversity.

[72]  Zhongshan Cheng,et al.  The Utility of Camptothecin as a Synergist of Bacillus thuringiensis var. kurstaki and Nucleopolyhedroviruses Against Trichoplusia ni and Spodoptera exigua , 2012, Journal of economic entomology.

[73]  A. Bodley,et al.  Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[74]  R. Shoemaker,et al.  Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts , 2004, Cancer Research.

[75]  W. L. Hunter,et al.  Topoisomerase inhibitors as anti-arthritic agents , 2008, Inflammation Research.

[76]  A. Bořkovec Control and management of insect populations by chemosterilants. , 1976, Environmental health perspectives.

[77]  H. Onishi,et al.  Macromolecular and nanotechnological modification of camptothecin and its analogs to improve the efficacy. , 2005, Current drug discovery technologies.

[78]  Z. Cao Preparation of 14-nitrocamptothecin derivatives by reactions of camptothecin with nitronium tetrafluoroborate in acidic solvents , 1996 .

[79]  F. Zunino,et al.  Synthesis and cytotoxic activity of new 9-substituted camptothecins. , 2008, Bioorganic & medicinal chemistry letters.

[80]  Nicholas H Oberlies,et al.  Camptothecin and taxol: historic achievements in natural products research. , 2004, Journal of natural products.

[81]  A. Bhattacharjee,et al.  Analysis of stereoelectronic properties of camptothecin analogues in relation to biological activity. , 2000, Bioorganic & medicinal chemistry.

[82]  M. Wani,et al.  Camptothecin and taxol: from discovery to clinic. , 1996, Journal of ethnopharmacology.

[83]  J. Zhang,et al.  The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[84]  M. L. Srinivas,et al.  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of an Orally Active Novel Camptothecin Analog, DRF‐1042, in Refractory Cancer Patients in a Phase I Dose Escalation Study , 2004, Journal of clinical pharmacology.

[85]  H. Lerchen Milestones in camptothecin research , 2002 .

[86]  Yong-tang Zheng,et al.  The Anti-HIV Actions of 7- and 10-Substituted Camptothecins , 2009, Molecules.

[87]  P. Yogeeswari,et al.  Camptothecin and its analogues: a review on their chemotherapeutic potential , 2005, Natural product research.

[88]  Liqin Zhang,et al.  Insecticidal Activity of Camptothecin Against Nilaparvata lugens, Brevicoryne brassicae, and Chilo suppressalis , 2010, Journal of economic entomology.

[89]  S. Hecht,et al.  Camptothecin: current perspectives. , 2004, Bioorganic & medicinal chemistry.

[90]  Xiran Lin,et al.  Camptothecin-mediated apoptosis and antiproliferation effect is accompanied by down-regulation of telomerase activity in HaCaT cells. , 2006, Journal of dermatological science.

[91]  Shiyou Li,et al.  Antifungal activity of camptothecin, trifolin, and hyperoside isolated from Camptotheca acuminata. , 2005, Journal of agricultural and food chemistry.

[92]  A. K. Kondapi,et al.  Neurotoxic activity of a topoisomerase-I inhibitor, camptothecin, in cultured cerebellar granule neurons. , 2010, Neurotoxicology.

[93]  A. Hizi,et al.  DNA-processing activities associated with the purified alpha, beta 2, and alpha beta molecular forms of avian sarcoma virus RNA-dependent DNA polymerase , 1982, Journal of virology.

[94]  D. Blair,et al.  Inhibition of human immunodeficiency virus (HIV-1) replication in vitro by noncytotoxic doses of camptothecin, a topoisomerase I inhibitor. , 1991, AIDS research and human retroviruses.

[95]  H. Varmus,et al.  Molecular biology of tumor viruses. RNA tumor viruses. , 1982 .

[96]  A. McPhail,et al.  Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2 , 1966 .

[97]  F. Zunino,et al.  Current status and perspectives in the development of camptothecins. , 2002, Current pharmaceutical design.

[98]  L. Lou,et al.  Semi-synthesis and biological activity of gamma-lactones analogs of camptothecin. , 2008, Bioorganic & medicinal chemistry letters.

[99]  H. Kantarjian,et al.  Phase I and pharmacokinetic study of a low‐clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia , 2004, Cancer.

[100]  H. Hansen,et al.  Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies. , 1972, Cancer chemotherapy reports.

[101]  C. Conover,et al.  Drug delivery systems. 2. Camptothecin 20-O-poly(ethylene glycol) ester transport forms. , 1996, Journal of medicinal chemistry.

[102]  P. Pantazis,et al.  Water-insoluble camptothecin analogues as potential antiviral drugs. , 1999, Journal of biomedical science.

[103]  M. Wani,et al.  Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogues. , 1986, Journal of medicinal chemistry.

[104]  Yanning Zhang,et al.  Characterization of DNA Topoisomerase-1 in Spodoptera exigua for Toxicity Evaluation of Camptothecin and Hydoxy-Camptothecin , 2013, PloS one.

[105]  W. Kingsbury,et al.  SYNTHESIS AND ANTI-HSV ACTIVITY OF METHYLENEDIOXY MAPPICINE KETONE ANALOGS , 1995 .

[106]  S. Niizuma,et al.  Synthesis of new camptothecin analogs with improved antitumor activities. , 2009, Bioorganic & medicinal chemistry letters.

[107]  H. Pinedo,et al.  The activity profile of the hexacyclic camptothecin derivative DX-8951f in experimental human colon cancer and ovarian cancer. , 2002, Biochemical pharmacology.

[108]  S. Segal,et al.  Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. , 1990, The EMBO journal.

[109]  L. Saltz,et al.  The camptothecins , 2003, The Lancet.

[110]  C. Takimoto,et al.  The Clinical Development of 9‐Aminocamptothecin , 2000, Annals of the New York Academy of Sciences.

[111]  Salwa A. H. Albohy,et al.  Synthesis, Spectroscopic, and Antimicrobial Activity Studies of Novel 10-Substituted Camptothecin Phosphorothioate Analogs , 2012 .

[112]  Shiyou Li Utilizing Camptotheca Products for Termite Control (US Patent 20020018762 and WO0200020) , 2002 .

[113]  E. Kleinerman,et al.  9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[114]  Yanning Zhang,et al.  Effects of camptothecin and hydroxycamptothecin on insect cell lines Sf21 and IOZCAS-Spex-II. , 2012, Pest management science.

[115]  R. Hertzberg,et al.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.

[116]  T. Ernst,et al.  Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy , 2003, Journal of NeuroVirology.

[117]  P. Sinko,et al.  A series of alpha-amino acid ester prodrugs of camptothecin: in vitro hydrolysis and A549 human lung carcinoma cell cytotoxicity. , 2010, Journal of medicinal chemistry.

[118]  P. Houghton,et al.  Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors , 2004, Cancer Chemotherapy and Pharmacology.

[119]  T. Tanaka,et al.  Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors. , 1987, Cancer research.

[120]  Y. Nishiyama,et al.  Role of DNA topoisomerase I in the replication of herpes simplex virus type 2 , 2005, Archives of Virology.

[121]  Xianyong Wei,et al.  Synthesis and antitumor activity of 20-O-linked nitrogen-based camptothecin ester derivatives. , 2004, Bioorganic & medicinal chemistry.

[122]  F. Zunino,et al.  Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts. , 2003, Molecular cancer research : MCR.

[123]  A. Bodley,et al.  Effects of camptothecin, a topoisomerase I inhibitor, on Plasmodium falciparum. , 1998, Biochemical pharmacology.

[124]  Juan Wang,et al.  Phosphate ester derivatives of homocamptothecin: synthesis, solution stabilities and antitumor activities. , 2010, Bioorganic & medicinal chemistry.

[125]  D. Steverding,et al.  Anti-trypanosomal activities of DNA topoisomerase inhibitors. , 2005, Acta tropica.

[126]  Zhiwei Yang,et al.  Synthesis and antitumor activity of novel 10-substituted camptothecin analogues. , 2006, Bioorganic & medicinal chemistry.

[127]  H. Burt,et al.  The effect of inhibiting topoisomerase I and II on the antiapoptotic response associated with pro-inflammatory crystals of calcium pyrophosphate dihydrate in human neutrophils , 2003, Inflammation Research.

[128]  D. Scudiero,et al.  Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. , 2002, Cancer research.

[129]  A. Venkateswarlu,et al.  In vitro cytotoxicity of 5-aminosubstituted 20(S)-camptothecins. Part 1. , 1999, Bioorganic & medicinal chemistry.

[130]  M. Bergeron,et al.  Treatment of Visceral Leishmaniasis with Sterically Stabilized Liposomes Containing Camptothecin , 2001, Antimicrobial Agents and Chemotherapy.

[131]  K. Lee,et al.  Design and one-pot synthesis of new 7-acyl camptothecin derivatives as potent cytotoxic agents. , 2012, Bioorganic & medicinal chemistry letters.

[132]  R. Danesi,et al.  Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: a preclinical study. , 2001, Toxicology and applied pharmacology.

[133]  X. Lin,et al.  Topical camptothecine in treatment of psoriasis. , 1988, International journal of dermatology.

[134]  Lin-jiang Tong,et al.  Synthesis and biological evaluation of new homocamptothecin analogs. , 2012, European journal of medicinal chemistry.

[135]  Lin Xr Effect of camptothecin in the treatment of psoriasis , 1987 .